Abstract
THE CURRENT INTEREST in regional cancer chemotherapy has been stimulated by several factors: (1) Although many cancer chemotherapeutic compounds have been developed and are currently undergoing clinical investigation in patients with far-advanced cancer, most reports have shown that thesystemicadministration of these agents has not resulted in significant practical value in the management of most common forms of cancer. (2) Many common forms of cancer, although beyond conventional therapy, remain localized throughout their evolution and produce symptoms and death from the locally confined, yet uncontrolled, growths. Regional cancer chemotherapy has been developed in an effort to increase the regional effect of antitumor agents in patients with advanced cancer whose tumors are within the distribution of accessible arteries. A method of regional administration of anticancer drugs has been reported which consists of the continuous arterial administration of an antimetabolite through catheters inserted into the major vessels supplying a tumor-bearing area.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
